Advertisement

Ads Placeholder
Loading...

Burning Rock Biotech Limited

BNR•NASDAQ
Healthcare
Medical - Diagnostics & Research
$16.20
$-0.10(-0.61%)
U.S. Market opens in 19h 53m

Burning Rock Biotech Limited (BNR) Stock Overview

Explore Burning Rock Biotech Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap17.4M
P/E Ratio-2.12
EPS (TTM)$-0.74
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$22.71
3 Months$36.97
1 Year Target$26.23

BNR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Burning Rock Biotech Limited (BNR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.12 and a market capitalization of 17.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.61%
5-Day Change
-13.88%
1-Month Change
-31.18%
3-Month Change
-17.68%
6-Month Change
79.60%
Year-to-Date (YTD) Change
-17.68%
1-Year Change
310.13%
3-Year Change
-41.09%
5-Year Change
-94.28%
All-Time (Max) Change
-93.42%

Contact Information

https://www.brbiotech.com
86 20 3403 7871
No. 5, Xingdao Ring Road North, Guangzhou, NaN, 510005

Company Facts

6,740 Employees
IPO DateJun 12, 2020
CountryCN
Actively Trading

Frequently Asked Questions